- Home
- LAZR vs AVIR Comparison
LAZR vs AVIR Comparison
Compare LAZR & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZR
- AVIR
- Stock Information
- Founded
- LAZR 2012
- AVIR 2012
- Country
- LAZR United States
- AVIR United States
- Employees
- LAZR N/A
- AVIR N/A
- Industry
- LAZR Auto Parts:O.E.M.
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- LAZR Consumer Discretionary
- AVIR Health Care
- Exchange
- LAZR Nasdaq
- AVIR Nasdaq
- Market Cap
- LAZR 140.7M
- AVIR 273.0M
- IPO Year
- LAZR N/A
- AVIR 2020
- Fundamental
- Price
- LAZR $2.77
- AVIR $3.73
- Analyst Decision
- LAZR Hold
- AVIR Hold
- Analyst Count
- LAZR 7
- AVIR 1
- Target Price
- LAZR $37.83
- AVIR $6.00
- AVG Volume (30 Days)
- LAZR 2.8M
- AVIR 398.9K
- Earning Date
- LAZR 08-12-2025
- AVIR 08-06-2025
- Dividend Yield
- LAZR N/A
- AVIR N/A
- EPS Growth
- LAZR N/A
- AVIR N/A
- EPS
- LAZR N/A
- AVIR N/A
- Revenue
- LAZR $73,313,000.00
- AVIR N/A
- Revenue This Year
- LAZR $16.78
- AVIR N/A
- Revenue Next Year
- LAZR $29.92
- AVIR N/A
- P/E Ratio
- LAZR N/A
- AVIR N/A
- Revenue Growth
- LAZR N/A
- AVIR N/A
- 52 Week Low
- LAZR $2.52
- AVIR $2.46
- 52 Week High
- LAZR $32.70
- AVIR $4.15
- Technical
- Relative Strength Index (RSI)
- LAZR 39.93
- AVIR 74.60
- Support Level
- LAZR $2.81
- AVIR $3.63
- Resistance Level
- LAZR $3.14
- AVIR $3.78
- Average True Range (ATR)
- LAZR 0.17
- AVIR 0.14
- MACD
- LAZR 0.04
- AVIR 0.02
- Stochastic Oscillator
- LAZR 40.80
- AVIR 100.00
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and Advanced Technologies and Services. The majority of its revenue is generated from the Autonomy Solutions segment, which engages in the design, manufacturing, and sale of LiDAR sensors, catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and various third-party customers. Geographically, the company derives its key revenue from North America.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).